ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Arizona » Internal Medicine

Top Internal Medicine Prescribers in Arizona

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RANDOLPH CLARK M.D.

Internal Medicine

25,100

$1.47M

1125
836 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $61

GERALD MUTHU M.D,

Internal Medicine

23,737

$1.45M

1169
982 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $61

PHILIP KACZAR M.D.

Internal Medicine

22,276

$1.53M

755
631 are 65+

15%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $61

DOUGLAS LAKIN M.D.

Internal Medicine

21,257

$1.56M

1285
1224 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $61

SURESH BALENALLI M.D.

Internal Medicine

21,032

$1.16M

697
515 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

SALMA JESMIN MD

Internal Medicine

20,489

$1.32M

472
335 are 65+

24%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $61

MATHEW BENJAMIN M.D.

Internal Medicine

20,363

$1.06M

1160
831 are 65+

14%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

SHEL-DON LEGARRETA MD

Internal Medicine

19,753

$867K

949
845 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $61

PAUL INGRAHAM MD

Internal Medicine

19,085

$972K

975
904 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $61

AMJAD RIAZ-UL-HAQ MD

Internal Medicine

18,685

$945K

1081
915 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $61

CHARLES KAPLAN MD

Internal Medicine

18,262

$1.01M

866
702 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

EDWARD TOKATLIAN M.D.

Internal Medicine

17,952

$1.06M

816
742 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $61

EDITA EXTRA-MENDOZA M.D.

Internal Medicine

17,812

$1.01M

1106
1025 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $61

KENNETH LEVY MD

Internal Medicine

17,448

$1.17M

908
798 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $61

KIANOUSH CHEYBANI M.D.

Internal Medicine

17,407

$963K

480
390 are 65+

25%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $61

GONZALO CELIS M.D.

Internal Medicine

17,115

$655K

1023
844 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

23%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $61

SUJIT MAGIYAWALA MD

Internal Medicine

16,606

$866K

1265
1134 are 65+

4%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $61

SERGIO PENAHERRERA MD

Internal Medicine

16,285

$1.09M

819
651 are 65+

1%
patients receiving schedule two controlled substances

Avg: 9%

4%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $61

EDWARD DUBROW MD

Internal Medicine

15,870

$763K

1203
1087 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $61

EDWARD KAY MD

Internal Medicine

15,782

$739K

943
817 are 65+

8%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $61

JAVED MALIK M.D.

Internal Medicine

15,763

$855K

823
716 are 65+

9%
patients receiving schedule two controlled substances

Avg: 9%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $61

MAYRA MELENDEZ MD

Internal Medicine

15,681

$588K

726
596 are 65+

7%
patients receiving schedule two controlled substances

Avg: 9%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $61

ROBERT ROGERS MD

Internal Medicine

15,552

$718K

767
649 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $61

ROBERT BIERMAN M.D.

Internal Medicine

15,229

$1.03M

904
792 are 65+

5%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $61

JABER ABAWI MD

Internal Medicine

15,096

$681K

630
501 are 65+

16%
patients receiving schedule two controlled substances

Avg: 9%

19%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank